Invex Therapeutics Ltd (ASX:IXC)

Invex Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	10	7	5	15	37	47
Market Cap Growth	54.76%	48.33%	-70.00%	-59.60%	-21.43%	-46.04%
Enterprise Value	4	1	-2	-10	6	14
Last Close Price	0.13	0.09	0.06	0.05	0.13	0.16
PS Ratio	42.65	29.20	3.72	32.74	204.12	-
PB Ratio	1.86	1.27	0.79	0.71	1.31	1.48
P/TBV Ratio	1.86	1.27	0.79	0.71	1.31	1.48
EV/Sales Ratio	19.18	3.85	-	-	32.02	-
Asset Turnover	0.04	0.04	0.08	0.02	0.01	-
Quick Ratio	24.79	24.79	14.18	14.50	29.36	49.71
Current Ratio	24.79	24.79	14.18	14.50	29.36	49.71
Return on Equity (ROE)	-8.72%	-8.72%	-12.20%	-31.18%	-13.05%	-8.09%
Return on Assets (ROA)	-7.65%	-7.65%	-9.22%	-20.43%	-8.10%	-5.16%
Return on Capital Employed (ROCE)	-13.50%	-13.50%	-37.50%	-40.30%	-14.20%	-7.60%
Earnings Yield	-4.88%	-7.13%	-36.41%	-51.56%	-10.63%	-4.82%
Buyback Yield / Dilution	-0.51%	-0.51%	-0.19%	-0.02%	-0.03%	-33.77%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.